Cannabinoid Encyclopedia

Health and effects

Cannabinoids and Immune modulation

What studies can tell us about cannabinoids and Immune modulation, including human research, early evidence, and important limits.

Updated July 2026 36 research sources Mostly early-stage research

The short answer

What does the research say about Immune modulation?

Researchers have studied cannabinoids in connection with Immune modulation. The current literature covers THC, Cannabinoids in general, Endocannabinoids, and PEA. This page brings together 12 human-study sources, 10 research reviews, and 14 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. There is no single answer that applies to every cannabinoid, dose, product, or person. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Immune modulation.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on Immune modulation covers THC, Cannabinoids in general, and Endocannabinoids; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about Immune modulation

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly preclinical

THC

Researchers have studied THC in connection with Immune modulation. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 2

Mostly mechanism-focused

Cannabinoids in general

Researchers have studied Cannabinoids in general in connection with Immune modulation. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 3

Mostly mechanism-focused

Endocannabinoids

Researchers have studied Endocannabinoids in connection with Immune modulation. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 4

Mostly mechanism-focused

PEA

Researchers have studied PEA in connection with Immune modulation. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 5

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

12 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

10 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

14 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on Immune modulation is not one kind of study. This source set includes 17 animal studies, 9 cell or laboratory studies, 9 narrative or expert reviews, and 1 systematic review or meta-analysis. 3

The recorded populations or models include people or patients (16 sources), animal models (9 sources), and cells or tissue models (6 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms (15 sources), cannabinoids and immune modulation research outcomes (9 sources), and skin, dermatology, inflammatory, or immune-modulation outcomes (9 sources). Closely related outcome names can still describe different measurements. 5

The Immune modulation source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies.

On this page, this source examines CBG and inflammation-related outcomes. 1

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
inflammation-related or immune outcomes
Evidence stage
evidence still limited

animal study

Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring.

On this page, this source examines THC and cannabinoids and immune modulation research outcomes. 2

Study type
animal study
Population or model
pediatric, adolescent, or developmental context
Outcome focus
cannabinoids and immune modulation research outcomes
Evidence stage
preclinical research

animal study

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy.

On this page, this source examines Cannabinoids and cannabinoids and immune modulation research outcomes and Cannabinoids activity involving CB2. 3

Study type
animal study
Population or model
animal models
Outcome focus
cannabinoids and immune modulation research outcomes and cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
mechanism-focused research

animal study

Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood-brain barrier alterations.

On this page, this source examines Endocannabinoids and cannabinoids and immune modulation research outcomes. 4

Study type
animal study
Population or model
people or patients
Outcome focus
cannabinoids and immune modulation research outcomes
Evidence stage
mechanism-focused research

animal study

Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice.

On this page, this source examines PEA and cannabinoids and immune modulation research outcomes. 5

Study type
animal study
Population or model
people or patients
Outcome focus
cannabinoids and immune modulation research outcomes
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on Immune modulation should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

Can cannabinoids help with Immune modulation?

Research exists, but there is not one answer for every cannabinoid or product. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why can studies reach different answers?

Studies may test different cannabinoids, doses, formulations, routes, people, and outcomes. Those differences can change the result. 8

What should I check in a study?

Check whether it studied people, what product and dose it used, what it measured, how long it lasted, and whether safety was reported. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. systematic review or meta-analysis; evidence still limited PubMed 33998900 DOI 10.1089/can.2020.0105
  2. 2
    Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. animal study; preclinical research PubMed 36746342 DOI 10.1016/j.bbi.2023.02.002
  3. 3
    Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy. animal study; mechanism-focused research PubMed 39334169 DOI 10.1186/s12974-024-03221-5
  4. 4
    Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood-brain barrier alterations. animal study; mechanism-focused research PubMed 40016352 DOI 10.1038/s41593-025-01891-9
  5. 5
    Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice. animal study; mechanism-focused research PubMed 35176443 DOI 10.1016/j.bbi.2022.02.008
  6. 6
    Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders. narrative or expert review; evidence still limited PubMed 40943579 DOI 10.3390/ijms26178657
  7. 7
    Cannabinoid receptor signaling. narrative or expert review; evidence still limited PubMed 16596771 DOI 10.1007/3-540-26573-2_2
  8. 8
    Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? narrative or expert review; evidence still limited PubMed 32471272 DOI 10.3390/ijms21113809
  9. 9
    Cannabinoids, inflammation, and fibrosis. narrative or expert review; evidence still limited PubMed 27435265 DOI 10.1096/fj.201600646r
  10. 10
    CB2 receptor in the CNS: From immune and neuronal modulation to behavior. narrative or expert review; evidence still limited PubMed 37164044 DOI 10.1016/j.neubiorev.2023.105226
  11. 11
    Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action. narrative or expert review; evidence still limited PubMed 35614947 DOI 10.3389/fphar.2022.908198
  12. 12
    Pharmacokinetics and pharmacodynamics of cannabinoids. narrative or expert review; evidence still limited PubMed 12648025 DOI 10.2165/00003088-200342040-00003
See all 36 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood-brain barrier alterations. animal study; mechanism-focused research / 1 linked research note PubMed 40016352
  2. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. animal study; preclinical research / 1 linked research note PubMed 36746342
  3. Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice. animal study; mechanism-focused research / 1 linked research note PubMed 35176443
  4. Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells. animal study; mechanism-focused research / 1 linked research note PubMed 34607960
  5. Impact of Chronic Moderate Exercise on Immune Cells and Cytokine Levels in Rats: Focus on the Endocannabinergic Pathway. animal study; mechanism-focused research / 1 linked research note PubMed 37962860
  6. Pharmacokinetics and pharmacodynamics of cannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 12648025
  7. Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy. animal study; mechanism-focused research / 2 linked research notes PubMed 39334169
  8. CB2 receptor in the CNS: From immune and neuronal modulation to behavior. narrative or expert review; evidence still limited / 1 linked research note PubMed 37164044
  9. Cannabinoid receptor signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 16596771
  10. Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. animal study; mechanism-focused research / 1 linked research note PubMed 41680865
  11. Anti-Inflammatory Effects of Minor Cannabinoids CBC, THCV, and CBN in Human Macrophages. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 37764262
  12. Cannabinol modulates the endocannabinoid system and shows TRPV1-mediated anti-inflammatory properties in human keratinocytes. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 39275884
  13. Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 36228902
  14. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. narrative or expert review; evidence still limited / 1 linked research note PubMed 38673788
  15. Cannabinoids, inflammation, and fibrosis. narrative or expert review; evidence still limited / 1 linked research note PubMed 27435265
  16. Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 41478536
  17. Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis. animal study; mechanism-focused research / 1 linked research note PubMed 40580876
  18. Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40568800
  19. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 33998900
  20. Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action. narrative or expert review; evidence still limited / 1 linked research note PubMed 35614947
  21. Cannabigerol Alleviates Liver Damage in Metabolic Dysfunction-Associated Steatohepatitis Female Mice via Inhibition of Transforming Growth Factor Beta 1. animal study; mechanism-focused research / 1 linked research note PubMed 40362835
  22. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease. animal study; mechanism-focused research / 1 linked research note PubMed 38662453
  23. Cannabinoid CB2 receptors enhance high-fat diet evoked peripheral neuroinflammation. animal study; mechanism-focused research / 1 linked research note PubMed 39173999
  24. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice. animal study; mechanism-focused research / 1 linked research note PubMed 30666359
  25. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. animal study; mechanism-focused research / 1 linked research note PubMed 26824325
  26. Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro. animal study; mechanism-focused research / 1 linked research note PubMed 38751621
  27. Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation. animal study; mechanism-focused research / 1 linked research note PubMed 36583304
  28. Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Inflammatory Bowel Disease. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40332343
  29. What we know and do not know about the cannabinoid receptor 2 (CB2). narrative or expert review; evidence still limited / 1 linked research note PubMed 24877594
  30. Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40791361
  31. Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders. narrative or expert review; evidence still limited / 1 linked research note PubMed 40943579
  32. Cannabinoid receptor 2 affect the inflammatory response in periodontitis by regulating macrophage M1/M2 polarization. animal study; mechanism-focused research / 1 linked research note PubMed 41310604
  33. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? narrative or expert review; evidence still limited / 1 linked research note PubMed 32471272
  34. Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis-BCG by inhibiting NF-κB signaling. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 39538989
  35. Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 41740200
  36. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. animal study; mechanism-focused research / 1 linked research note PubMed 36830745